BLOCKADE OF ANGIOTENSIN II TYPE I RECEPTOR (AT1) AND CC CHEMOKINE RECEPTOR 2 (CCR2) HETEROMERS IN PROGRESSIVE CHRONIC KIDNEY DISEASE

被引:0
|
作者
Zhang, Y. [1 ]
Kelly, R. [1 ]
Cox, A. [1 ]
Williams, J.
Mccall, L.
Pfleger, K. [2 ]
Kelly, D. [1 ]
机构
[1] Univ Melbourne, Melbourne, Vic 3010, Australia
[2] Univ Western Australia, Nedlands, WA 6009, Australia
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
083
引用
收藏
页码:36 / 36
页数:1
相关论文
共 50 条
  • [1] Blockade of angiotensin II type 1 receptor attenuates steatohepatitis via CC-chemokine ligand 2 receptor
    Kudo, Hiroshi
    Yata, Yutaka
    Takahara, Terumi
    Nakayama, Yasuhiro
    Kawai, Kengo
    Kanayama, Masami
    Sugiyama, Toshihiro
    GASTROENTEROLOGY, 2007, 132 (04) : A737 - A737
  • [2] Inducing Receptor Degradation as a Novel Approach to Target CC Chemokine Receptor 2 (CCR2)
    Zacarias, Natalia V. Ortiz
    Roth, Sascha
    Broekhuis, Jeremy D.
    van der Es, Daan
    Moreau, Kevin
    Heitman, Laura H.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)
  • [3] Inducing receptor degradation as a novel approach to target CC chemokine receptor 2 (CCR2)
    Zacarias, Natalia Ortiz
    Broekhuis, Jeremy
    van der Es, Daan
    Heitman, Laura H.
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 657 - 658
  • [4] The presence of leukocyte CC-Chemokine receptor 2 (CCR2) in CCR2 knockout mice promotes atherogenesis
    Jian, G
    Van Eck, M
    von der Thüsen, JH
    Maeda, N
    Benson, GM
    Groot, PH
    Van Berkel, TJ
    CIRCULATION, 2003, 108 (17) : 65 - 65
  • [5] Novel, orally bioavailable γ-aminoamide CC chemokine receptor 2 (CCR2) antagonists
    Pasternak, Alexander
    Marino, Dominick
    Vicario, Pasquale P.
    Ayala, Julia Marie
    Cascierri, Margaret A.
    Parsons, William
    Mills, Sander G.
    MacCoss, Malcolm
    Yang, Lihu
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (16) : 4801 - 4804
  • [6] Basophil CC chemokine receptor 2 (CCR2) expression in hymenoptera venom anaphylaxis
    Koren, A.
    Vantur, R.
    Kopac, P.
    Zidarn, M.
    Erzen, R.
    Korosec, P.
    ALLERGY, 2019, 74 : 240 - 240
  • [7] Discovery of trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonists
    Cherney, Robert J.
    Brogan, John B.
    Mo, Ruowei
    Lo, Yvonne C.
    Yang, Gengjie
    Miller, Persymphonie B.
    Scherle, Peggy A.
    Molino, Bruce F.
    Carter, Percy H.
    Decicco, Carl P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (03) : 597 - 601
  • [8] Monocyte subtypes and the CCR2 chemokine receptor in cardiovascular disease
    Franca, Carolina N.
    Izar, Maria C. O.
    Hortencio, Marinella N. S.
    do Amaral, Jonatas B.
    Ferreira, Carlos E. S.
    Tuleta, Izabela D.
    Fonseca, Francisco A. H.
    CLINICAL SCIENCE, 2017, 131 (12) : 1215 - 1224
  • [9] Angiotensin II type 2 receptor in chronic kidney disease: the good side of angiotensin II?
    Griffin, Karen A.
    Bidani, Anil K.
    KIDNEY INTERNATIONAL, 2009, 75 (10) : 1006 - 1008
  • [10] Capped diaminopropionamide-glycine dipeptides are inhibitors of CC chemokine receptor 2 (CCR2)
    Carter, Percy H.
    Brown, Gregory D.
    Friedrich, Sarah R.
    Cherney, Robert J.
    Tebben, Andrew J.
    Lo, Yvonne C.
    Yang, Gengjie
    Jezak, Heather
    Solomon, Kimberly A.
    Scherle, Peggy A.
    Decicco, Carl P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (19) : 5455 - 5461